The Lancet Retracts Cardiac Stem Cell Clinical Trial Paper

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.
https://www.the-scientist.com/news-opinion/the-lancet-retracts-cardiac-stem-cell-clinical-trial-paper-65598/amp

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.